Zobrazeno 1 - 10
of 17
pro vyhledávání: '"A V, Otrashevskaia"'
Autor:
A. S. Oksanich, T. G. Samartseva, K. V. Kaa, E. V. Otrashevskaia, A. G. Krasko, A. G. Laputina, N. A. Netesova, G. M. Ignatyev
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 3, Pp 279-293 (2024)
INTRODUCTION. The completeness of virus inactivation and the identity of the vaccine strain are essential parameters for the safety and quality of inactivated virus vaccines, which should be controlled during vaccine development and production. Curre
Externí odkaz:
https://doaj.org/article/e4af3004a74a412b94cb3db07b5803cc
Autor:
N. A. Netesova, M. A. Abdurashitov, T. G. Samartseva, O. V. Klimovich, A. S. Oksanich, Е. V. Otrashevskaia, G. M. Ignatyev
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 3, Pp 270-278 (2024)
INTRODUCTION. Chikungunya virus (CHIKV) genotyping involves sequencing fractions of genes encoding E1, E2, and nsP1 proteins or the entire genome of the virus. Available reagent kits or polymerase chain reaction protocols cannot be used for CHIKV gen
Externí odkaz:
https://doaj.org/article/05fbe65f3d8846618b67160f30103918
Autor:
Elena V. Otrashevskaia, Konstantin V. Kaa, Alexey S. Oksanich, Nikita V. Murashko, Alexander G. Kusliy, Anatoliy G. Krasko, Vitaly V. Zverev, George M. Ignatyev
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 101, Iss 2, Pp 193-207 (2024)
Introduction. Chikungunya virus infection is a problem for the health care system of affected regions due to the lack of specific prevention, as well as effective antiviral drugs. The critical role of cellular immunity in viral control and clearance
Externí odkaz:
https://doaj.org/article/d8e29b512151446ebb778be1499f2240
Autor:
D T Abdurakhmanov, A V Otrashevskaia
Publikováno v:
Терапевтический архив, Vol 86, Iss 11, Pp 100-104 (2014)
The goal of treatment for chronic hepatitis B (CHB) is now to improve quality of life and to prevent the poor outcomes of the disease rather than to eliminate the virus from the body. This goal may be achieved via the long-term maintenance of aviremi
Externí odkaz:
https://doaj.org/article/e76945fdfba942fca014b8059ef7161d
Publikováno v:
Voprosy virusologii. 58(6)
In this work we report the mumps vaccine virus shedding based on the laboratory confirmed cases of the mumps virus (MuV) infection. The likely epidemiological sources of the transmitted mumps virus were children who were recently vaccinated with the
Publikováno v:
Voprosy virusologii. 57(4)
Two enzyme immunoassays (ELISA) for mumps antibody detection using the Enzygnost (Germany) and Parotit-screen (Russia) were comparatively assayed using sera of randomly assigned 70 healthy young adult volunteers. The neutralization test (NT) was perf
Publikováno v:
Voprosy virusologii. 56(4)
The neurovirulence and replication potential of several mumps virus strains, including Leningrad-3 mumps vaccine virus (FSUE SIC "Microgen", Russia) and wild type strains isolated in the Novosibirsk Region (Russia), were assessed in rat tests. The me
[Specific humoral immunity after single immunization with mumps vaccine: data of a 3-year follow-up]
Publikováno v:
Voprosy virusologii. 56(3)
The level and spectrum of humoral specific immunity were studied in 60 volunteers immunized with Russian mumps vaccine. Specific IgG levels were measured by enzyme immunoassay (EIA) and neutralization test using the Leningrad-3 (L-3) mumps virus (MV)
Publikováno v:
Voprosy virusologii. 55(6)
Postvaccination immunity was studied in the children and teenagers without a history of clinical mumps infection, who had been immunized with the Leningrad-3 mumps vaccine. The level of specific lgG in ELISA and that and spectrum of their neutralizin
Publikováno v:
Voprosy virusologii. 55(4)
The functional state of immunity was evaluated from the avidity index (AI) of specific antibodies (IgG) and the level and spectrum of their neutralizing activity. The study recruited 200 subjects immunized with Russian vaccine against mumps according